Novel insights into targeting ATP-binding cassette transporters for antitumor therapy

Research output: Contribution to journalArticlepeer-review

Abstract

ATP-binding cassette (ABC) transporters are a large family of proteins implicated in physiological cellular functions. Selected components of the family play a well-recognized role in extruding conventional cytotoxic antitumor agents and molecularly targeted drugs from cells. Some lines of evidence also suggest links between transporters and tumor cell survival, in part unrelated to efflux. However, the study of the precise mechanisms regulating the function of drug transporters (e.g., posttranslational modifications such as glycosylation) is still in its infancy. A better definition of the molecular events clarifying the regulation of transporter levels including regulation by microRNAs may contribute to provide new molecular tools to target such a family of transporters. The present review focuses on the biological aspects that implicate ABC transporters in resistance of tumor cells, including cancer stem cells. Molecular analysis of well-known preclinical systems as well as of cancer stem cell models supports the notion that ABC transporters represent amenable targets for modulation of the efficacy of antitumor agents endowed with different molecular features. Recent achievements regarding tumor cell biology are expected to provide a rationale for developing novel inhibitors that target ABC transporters implicated in drug resistance.

Original languageEnglish
Pages (from-to)4237-4249
Number of pages13
JournalCurrent Medicinal Chemistry
Volume18
Issue number27
DOIs
Publication statusPublished - Sep 2011

Keywords

  • ABC transporters
  • BCRP
  • Cancer stem cells
  • Drug resistance
  • Drug targets
  • Glycosylation
  • MiRNAs
  • MRP
  • P-gp
  • Transporter Inhibitor

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'Novel insights into targeting ATP-binding cassette transporters for antitumor therapy'. Together they form a unique fingerprint.

Cite this